Human trials of first Thai developed COVID-19 vaccine begins Monday

1 Oct 11:20 Key points summarised by AI

ChulaCov19, Thailand's first domestically developed mRNA COVID-19 vaccine, commenced human trials today, marking a significant step in national vaccine production.
The trials involve two phases with healthy volunteers (ages 18-75) to determine the optimal dosage and assess the vaccine's safety and efficacy.
Successful completion of both trial phases could fast-track approval for mass production before mid-2022, potentially bypassing a third phase.
Developed by Chula Vaccine Research Centre (CVRC), the vaccine demonstrated promising results in animal tests and exhibits good heat tolerance, simplifying storage and distribution.
Researchers plan further animal experiments to address virus mutations, with human trials for variants like Alpha, Delta, Gamma, and Beta slated for the last quarter of this year.

Suchada: Meet the reluctant star of Thailand’s cryptic crypto drama

Yesterday 15:38 Key points summarised by AI

Thai MP Suchada Zhang Thaensap faces intense scrutiny over her husband’s substantial 1.84 billion baht wealth, with opposition lawmakers alleging connections to international scam networks.
A significant portion of her husband, Taiyang Zhang's, declared assets includes a 1.44 billion baht loan to the now-bankrupt cryptocurrency hedge fund Three Arrows Capital, which still owes him 1.34 billion baht.
Opposition MP Rangsiman Rome accused Suchada's husband of links to online scam networks and gambling sites, prompting Suchada to vehemently deny the claims, demand evidence, and file a defamation complaint.
Taiyang Zhang's background includes co-founding Ren Protocol, later sold to Alameda Research (linked to the FTX collapse), and some of his former associates have been convicted in crypto company failures.
Suchada, a former actress and first-time MP, maintains her husband's innocence, while her party leaders have distanced themselves from the allegations, deeming it a private matter.